Abstract P2-07-01: Association of TILs with clinical parameters, recurrence score, and prognosis in patients with early HER2-negative breast cancer (BC) – A translational analysis of the prospective WSG planB trial

Autor: Toralf Reimer, F Heinisch, Nadia Harbeck, O Gluz, U. Nitz, Benno Nuding, Matthias Christgen, Michael R. Clemens, Christer Svedman, Ronald E. Kates, Cornelia Liedtke, Friedrich Feuerhake, S Shak, H.H. Kreipe, Stefan Kraemer

Publikováno v: Cancer Research. 76:P2-07

Introduction: Tumor-infiltrating lymphocytes (TILs) have been associated with prognosis and with chemotherapy response among patients with BC, particularly in presence of high-risk features. The WSG planB trial randomized 2448 patients with HER2- N0/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dcdf90d173393c772a8fe453ee48a18f
https://doi.org/10.1158/1538-7445.sabcs15-p2-07-01

Book Review: A Review of 'Dictionary of Rubber'

Autor: K. F. Heinisch, J. C. Ambelang

Publikováno v: Tire Science and Technology. 3:128-129

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::91b2d5d48a4f3573bf0f06dd27155473
https://doi.org/10.2346/1.2167198

Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.

Autor: Kolberg-Liedtke C; Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany. cornelia.kolberg-liedtke@charite.de., Gluz O; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Heinisch F; Institute of Pathology, Medical School Hannover, Hannover, Germany., Feuerhake F; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Kreipe H; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Clemens M; Department of Gynecology and Obstetrics, Evangelical Hospital, Bergisch Gladbach, Germany., Nuding B; Department of Gynaecology and Obstertrics, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Malter W; Department of Gynaecology and Obstetrics, University Clinics Rostock, Rostock, Germany., Reimer T; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany., Wuerstlein R; West German Study Group, Mönchengladbach, Germany.; Genomic Health, Inc., Redwood City, CA, USA., Graeser M; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Shak S; Genomic Health, Inc., Redwood City, CA, USA., Nitz U; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Kates R; West German Study Group, Mönchengladbach, Germany., Christgen M; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Harbeck N; West German Study Group, Mönchengladbach, Germany.; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2020 May 14; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2020 May 14.